SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults
Open Access
- 26 November 2021
- journal article
- research article
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 8 (11)
Abstract
Adults infected with SARS-CoV-2 may develop a multisystem inflammatory syndrome (MIS-A) characterized by elevated inflammatory markers and multisystem organ involvement. We report the case of a patient who presented with fever and vomiting at hospital admission. He tested positive for SARS-CoV-2 infection and blood tests showed elevated inflammatory markers. The patient developed acute cardiac dysfunction and shock in less than 24 hours and the echocardiogram revealed an LVEF of 30%. He was discharged 3 weeks later fully recovered. MIS-A should be considered if a compatible syndrome is observed in patients with evidence of SARS-CoV-2 infection by PCR test or serology.Keywords
This publication has 5 references indexed in Scilit:
- Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescentRheumatology International, 2021
- American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2Arthritis & Rheumatology, 2021
- Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care UnitsChest, 2021
- Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19Circulation: Heart Failure, 2020